New tricks for many old drugs to kill cancer cells

Credit : Susanna Hamilton, Broad Communications

Article Highlights

A study testing thousands of medicines in hundreds of cancer cell lines in the lab uncovers new tricks for many old drugs
Drugs for diabetes, inflammation, alcoholism — and even for treating arthritis in dogs — can also kill cancer cells in the lab, according to a study by scientists at the Broad Institute of MIT and Harvard and Dana-Farber Cancer Institute. The researchers systematically analyzed thousands of already developed drug compounds and found nearly 50 that have previously unrecognized anti-cancer activity. The surprising findings, which also revealed novel drug mechanisms and targets, suggest a possible way to accelerate the development of new cancer drugs or repurpose existing drugs to treat cancer
“We thought we’d be lucky if we found even a single compound with anti-cancer properties, but we were surprised to find so many,”
The study also marks the first time researchers screened the entire collection of mostly non-cancer drugs for their anti-cancer capabilities
They found nearly 50 non-cancer drugs — including those initially developed to lower cholesterol or reduce inflammation — that killed some cancer cells while leaving others alone
Some of the compounds killed cancer cells in unexpected ways. “Most existing cancer drugs work by blocking proteins, but we’re finding that compounds can act through other mechanisms,” said Corsello. Some of the four-dozen drugs he and his colleagues identified appear to act not by inhibiting a protein but by activating a protein or stabilizing a protein-protein interaction
Most of the non-oncology drugs that killed cancer cells in the study did so by interacting with a previously unrecognized molecular target
The researchers hope to study the repurposing library compounds in more cancer cell lines and to grow the hub to include even more compounds that have been tested in humans

The Complete Story: Dozens of non-oncology drugs can kill cancer cells

Broad Institute | Dana-Farber Cancer Institute

Go deeper with Bing News on:

Killing cancer cells

A New Line of Defense in Blood Cancer: Natural Killer Cell Therapy
Natural killer cell therapy is making strides in blood cancer research, but there’s still much more to learn. Bob Schulz knew something was wrong when he had a hard time walking up the hill while ...
New cancer treatment wipes out tumours in terminally ill
A new cancer treatment can wipe out tumours in terminally ill patients, scientists have revealed. According to researchers at the Institute of Cancer Research (ICR), London, and the Royal Marsden NHS ...
Anti-cancer drug derived from fungus shows promise in clinical trials
A new industry-academic partnership between the University of Oxford and biopharmaceutical company NuCana as found that chemotherapy drug NUC-7738, derived from a Himalayan fungus, has 40 times ...
ADC Has Curative Effect On Cell Surface Protein In Neuroblastoma
Physician scientists in the Cancer Center at Children s Hospital of Philadelphia CHOP have developed a preclinical potent therapy attached to an antibody that targets a surface protein expressed in ...
Explosive New Study Says Exercise Can Stop Cancer In Its Tracks
New research shows that myokines produced by exercise are capable of both suppressing cancer tumor growth and fighting cancer cells.

Go deeper with Google Headlines on:

Killing cancer cells

New treatments bring hope for those with triple-negative breast cancer - ABC News
October 11, 2021
Hot magnets that kill cancer cells while sparing healthy ones - BusinessLine
September 13, 2021
Anti-cancer drug derived from fungus shows promise in clinical trials - Medical Xpress
October 11, 2021
Fungus-derived cancer killing drug by Oxford University shows promise - PharmaTimes
October 8, 2021
CAR-T cells require an abundance of antigens to efficiently kill solid tumors - News-Medical.net
October 5, 2021

Go deeper with Bing News on:

Anti-cancer activity

Anti-cancer drug derived from fungus shows promise in clinical trials
A new industry-academic partnership between the University of Oxford and biopharmaceutical company NuCana as found that chemotherapy drug NUC-7738, derived from a Himalayan fungus, has 40 times ...
Breast Cancer Awareness 2021: Breast cancer can affect anyone at any age
October is breast cancer awareness month, an annual campaign to raise both awareness and money for research and treatment. Many organizations participate with fund raising activities such as the Susan ...
CTX-009 (ABL001/ES104) Clinical Data Presented Today at the New Drugs on the Horizon Plenary Session of the 2021 AACR-NCI-EORTC International Conference on Molecular Targets ...
CTX-009 (ABL001/ES104) clinical data presented today at the New Drugs on the Horizon plenary session of 2021 AACR-NCI-EORTC International Conference ...
Forma Therapeutics’ FT-7051 is Well-tolerated and Demonstrates Evidence of Activity in Initial Results from Ongoing Phase 1 Courage Study in Men with Metastatic Castration ...
Forma Therapeutics Holdings, Inc. (Nasdaq: FMTX), a clinical-stage biopharmaceutical company focused on sickle cell disease, prostate cancer and other ...
Yale spinout shows how targeting cancer cells' acidic environment might enhance immunotherapy
Yale University spinout Cybrexa Therapeutics has developed a peptide-drug conjugate that, instead of aiming for a specific antigen, targets the acidic environment of cancer cells to deliver a toxic ...